Publication | Closed Access

Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators

NanoparticlesNanomedicineInflammationAnti-inflammatoryEngineeringTherapeutic NanomaterialsNanobiotechnologyMedicineImmunologyPotential Novel TherapyInflammatory MediatorsMultiple SclerosisImmunotherapyNeuroimmunologyNeuroinflammation